{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:53:12Z","timestamp":1776462792307,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging Clinics of North America"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.mric.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:29:44Z","timestamp":1771417784000},"page":"231-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac MR Imaging of Flow Abnormalities in Hypertrophic Cardiomyopathy Phenotypes"],"prefix":"10.1016","volume":"34","author":[{"given":"Kana","family":"Fujikura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark V.","family":"Sherrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Massera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Axel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mric.2026.01.004_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2023.04.005","article-title":"How common is hypertrophic cardiomyopathy. really?: disease prevalence revisited 27 years after CARDIA","volume":"382","author":"Massera","year":"2023","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.mric.2026.01.004_bib2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s13244-018-0656-8","article-title":"Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings","volume":"9","author":"Soler","year":"2018","journal-title":"Insights Imaging"},{"issue":"3","key":"10.1016\/j.mric.2026.01.004_bib3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/hrt.2004.036103","article-title":"Mid systolic septal deceleration in hypertrophic cardiomyopathy: clinical value and insights into the pathophysiology of outflow tract obstruction by tissue Doppler echocardiography","volume":"91","author":"Breithardt","year":"2005","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.mric.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jacc.2006.10.070","article-title":"Effect of obstruction on longitudinal left ventricular shortening in hypertrophic cardiomyopathy","volume":"49","author":"Barac","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.mric.2026.01.004_bib5","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.echo.2024.05.009","article-title":"On the cause of systolic anterior motion in obstructive hypertrophic cardiomyopathy","volume":"37","author":"Sherrid","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"10.1016\/j.mric.2026.01.004_bib6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jcmg.2022.11.013","article-title":"Apical aneurysms and mid-left ventricular obstruction in hypertrophic cardiomyopathy","volume":"16","author":"Sherrid","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.mric.2026.01.004_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mric.2026.01.004_bib8","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1038\/s41598-022-10389-4","article-title":"Comparison of mortality and cause of death between adults with and without hypertrophic cardiomyopathy","volume":"12","author":"Kwon","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.mric.2026.01.004_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.CIR.97.1.41","article-title":"Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy","volume":"97","author":"Sherrid","year":"1998","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.mric.2026.01.004_bib10","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.jacc.2021.07.065","article-title":"Randomized trial of metoprolol in patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Dybro","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.mric.2026.01.004_bib11","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.jacc.2024.08.015","article-title":"Effect of aficamten on cardiac structure and function in obstructive hypertrophic cardiomyopathy: SEQUOIA-HCM CMR Substudy","volume":"84","author":"Masri","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mric.2026.01.004_bib12","first-page":"800","article-title":"The revolution of cardiac myosin inhibitors in patients with hypertrophic cardiomyopathy","volume":"40","author":"Haraf","year":"2024","journal-title":"Can J Cardiol"},{"issue":"7","key":"10.1016\/j.mric.2026.01.004_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.medj.2024.06.001","article-title":"Two cardiac myosin inhibitors in the treatment of obstructive hypertrophic cardiomyopathy","volume":"5","author":"Desai","year":"2024","journal-title":"Med"},{"issue":"17","key":"10.1016\/j.mric.2026.01.004_bib14","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.124.069378","article-title":"Long-term outcomes after septal reduction therapies in obstructive hypertrophic cardiomyopathy: insights from the SHARE Registry","volume":"150","author":"Maurizi","year":"2024","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mric.2026.01.004_bib15","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/ejhf.3372","article-title":"Safety and efficacy of aficamten in patients with non-obstructive hypertrophic cardiomyopathy: a 36-week analysis from FOREST-HCM","volume":"26","author":"Masri","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.mric.2026.01.004_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.017185","article-title":"Serial changes in ventricular strain in symptomatic obstructive hypertrophic cardiomyopathy treated with mavacamten: insights from the VALOR-HCM trial","volume":"17","author":"Desai","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"issue":"15","key":"10.1016\/j.mric.2026.01.004_bib17","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2016.01.071","article-title":"The mitral valve in obstructive hypertrophic cardiomyopathy: a test in context","volume":"67","author":"Sherrid","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.mric.2026.01.004_bib18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.echo.2018.01.022","article-title":"Standardized goal-directed valsalva maneuver for assessment of inducible left ventricular outflow tract obstruction in hypertrophic cardiomyopathy","volume":"31","author":"Kumar","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"issue":"23","key":"10.1016\/j.mric.2026.01.004_bib19","first-page":"2324","article-title":"AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the management of hypertrophic cardiomyopathy: a report of the American heart Association\/American College of Cardiology Joint Committee on clinical practice Guidelines","volume":"83","author":"Writing Committee","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mric.2026.01.004_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jmri.24962","article-title":"4D flow MRI and T1 -Mapping: assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy","volume":"43","author":"van Ooij","year":"2016","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"10.1016\/j.mric.2026.01.004_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101195","article-title":"Clinical course and treatment of patients with apical aneurysms due to hypertrophic cardiomyopathy","volume":"3","author":"Sherrid","year":"2024","journal-title":"JACC Adv"},{"issue":"12","key":"10.1016\/j.mric.2026.01.004_bib22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.echo.2015.08.015","article-title":"Doppler systolic signal void in hypertrophic cardiomyopathy: apical aneurysm and severe obstruction without elevated intraventricular velocities","volume":"28","author":"Po","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"10.1016\/j.mric.2026.01.004_bib23","first-page":"783","article-title":"Doppler echocardiography underestimates the prevalence and magnitude of mid-cavity obstruction in patients with symptomatic hypertrophic cardiomyopathy","volume":"91","author":"Malcolmson","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.mric.2026.01.004_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0894-7317(97)70112-3","article-title":"Mid-systolic drop in left ventricular ejection velocity in obstructive hypertrophic cardiomyopathy\u2014The lobster claw abnormality","volume":"10","author":"Sherrid","year":"1997","journal-title":"J Am Soc Echocardiography"},{"issue":"3","key":"10.1016\/j.mric.2026.01.004_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014907","article-title":"Apical Ischemia is a universal feature of apical hypertrophic cardiomyopathy","volume":"16","author":"Hughes","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.mric.2026.01.004_bib26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12350-010-9196-4","article-title":"Multi-modality imaging of diastolic function","volume":"17","author":"Salerno","year":"2010","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.mric.2026.01.004_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jtcvs.2019.03.088","article-title":"Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure","volume":"159","author":"Nguyen","year":"2020","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Magnetic Resonance Imaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968926000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968926000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:10:02Z","timestamp":1776460202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064968926000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1064968926000048"],"URL":"https:\/\/doi.org\/10.1016\/j.mric.2026.01.004","relation":{},"ISSN":["1064-9689"],"issn-type":[{"value":"1064-9689","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac MR Imaging of Flow Abnormalities in Hypertrophic Cardiomyopathy Phenotypes","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mric.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}